Advocate · Speaker · Patient Safety
Turning Pain into Purpose — Exposing the Hidden Epidemic of Antidepressant Harm
Danielle Gansky is a patient safety advocate, speaker, and leading voice in the deprescribing movement. After being prescribed psychiatric medications at age 7 and sustaining a life-altering neurological injury from SSRI withdrawal, she has made it her mission to raise awareness of antidepressant harms and advocate for evidence-based tapering, greater transparency about antidepressant risks, and policy reforms that better protect patients.
The Advocacy & Issues
The Hidden Epidemic of Antidepressant Harms
The Withdrawal Crisis
Many people expect antidepressant withdrawal to be mild and short-lived. In reality, withdrawal can be severe, prolonged, and disabling — in some cases developing into protracted withdrawal, a debilitating drug-induced nervous system injury. These symptoms are mistaken for relapse of the “underlying condition,” and patients are often placed back on medication or prescribed additional psychiatric drugs instead of receiving appropriate withdrawal-informed care.
No Safe Off-Ramp
There is currently no standardized, evidence-based pathway for safely discontinuing antidepressants after long-term use. Most patients are advised by doctors to taper too quickly, despite growing evidence that safer discontinuation may require a gradual, individualized approach over many months — or, in some cases, years.
Antidepressant Injuries
For some people, the effects of antidepressants do not end when the medication is stopped. Persistent sexual dysfunction (PSSD), emotional blunting, cognitive impairment, and other lasting neurological injuries can continue for months, years, or indefinitely after discontinuation.
Patients Can't Consent to Risks They Aren't Told About
Many serious and life-altering antidepressant harms remain absent from U.S. FDA antidepressant warning labels and are not recognized by healthcare professionals. Without accurate and complete information, patients cannot make truly informed decisions about whether to start, continue, or stop an antidepressant.
A Public Health Crisis
With approximately 30–44 million Americans taking antidepressants—most long-term—even a small percentage of patients developing antidepressant-related harms would translate into millions of people affected, making this a significant public health crisis.
@daniellegansky
Danielle Gansky on Instagram
Connect with Danielle
For speaking engagements, interviews, and advocacy inquiries.